Trial
NCT00855413
HIV Viremia and Persistence in Acutely HIV-Infected Patients Treated With Darunavir/Ritonavir and Etravirine
Phase IVTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of North Carolina, Chapel Hill
Collaborators
Janssen Pharmaceuticals
Condition
Acute HIV Infection
Intervention
Darunavir
Why stopped
Study halted by sponsor due to slow enrollment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-10-17